BRONX, N.Y., Feb. 12, 2017 -- New York City and Bronx area Optometrist Pelham Parkway Vision Center is pleased to announce that they will be making PROKERA® products available to their clients. Treatments with PROKERA® can bring profound relief to optometry clients who are suffering the effects of dry eye and related conditions.
PROKERA® instantly helps to reduce inflammation and accelerate the healing time for dry, inflamed eyes. It is a biologic corneal bandage device that can treat and heal eye conditions such as keratitis (dry eye), persistent epithelial defects, recurrent corneal erosions, neurotrophic corneas, filamentary keratitis, herpetic ulcers, and numerous other diseases of the ocular surface.
Dry eye refers to the inability of the eye to produce tears to help nourish and lubricate the eye. In some cases, sufficient tears are produced, but they are of poor quality, as they do not contain enough healthy oils and mucus. As a result, vision and eye health suffers. Dry eye often affects older adults and can become worse with age. Persons with the condition of dry eye often experience a gritty sensation in the eyes that can burn, feel itchy or cause general irritation. In advanced cases, the eyes can become scratched and damaged, impairing vision, eye health, and quality of life.
When treating dry eye, optometrists aim to help restore and maintain optimal amounts of moisture in the eyes to reduce discomfort and promote health. PROKERA® devices are the only products of their kind that have been cleared by the FDA as a solution for reducing inflammation and promoting the healing and regeneration of the ocular surface.
PROKERA® products promote natural, therapeutic healing with their content of amniotic membrane tissue. The PROKERA® company’s proprietary CryoTek® processing method causes natural therapeutic actions and healthy biological activity so that damaged eye surfaces can heal.
PROKERA® products can bring improved tear production, reduced inflammation and pain, less scarring, clear corneas, improved vision, and better eye health. Quality of life is improved as discomfort fades.
Optometrist Dr. Diana Ilyasova of Pelham Parkway Vision Center appreciates the PROKERA® solution due to its safety, effectiveness, and lack of risk of IOP spikes (intraocular pressure). PROKERA® can also be used in conjunction with other healing solutions such as topical agents.
Dr. Oleg Lisitsyn says, “We are pleased to offer innovative PROKERA® products in our Bronx optometry clinic. We look forward to improving the quality of life of our clients with PROKERA® products.”
Pelham Parkway Vision Center is located at 735 Lydig Avenue in Bronx, New York. Those in New York City area and surrounding communities who would like to learn more about PROKERA® treatments for dry eye or book an appointment may do so by calling (347) 897-5570. Additional information is also available on their website at http://pelhamparkwayvisioncenter.com/.
Pelham Parkway Vision Center, (347) 897-5570


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



